Results for Aplastic Anemia

1 - 10 of 14
Peter Kurre, MD
Peter Kurre

Dr. Kurre's laboratory has longstanding expertise in Fanconi Anemia (FA), a genetic condition with prominent hematologic complications. With training in transplantation and hematopoietic stem cell biology, he hopes to improve the understanding of the progressive hematopoietic failure in patients with bone marrow failure and FA, broaden diagnostic approaches, and develop next generation therapies.

E-mail:
kurrep [at] chop.edu
Timothy S. Olson, MD, PhD
Timothy S. Olson Headshot

Dr. Olson aims to improve diagnostics and treatment of bone marrow failure (BMF) syndromes, and to improve clinical hematopoietic stem cell transplantation (HSCT) outcomes. He conducts clinical trials of HSCT for non-malignant hematologic diseases. His laboratory explores both basic and translational research focused on genomics of BMF and the impact of BMF on hematopoietic niche function during HSCT.

E-mail:
olsont [at] chop.edu

In the News: Podcasts, Vaccinations, Golf Cart Injuries, COVID-19, NIH Funding

Published on
Oct 15, 2021
in Cornerstone Blog
In the News
This week’s news roundup includes a podcast with the CSO, new studies regarding COVID-19 effects, golf cart injuries, and new NIH funding.

In the News: Aplastic Anemia, Boricua Mutation, Oligodendroglioma, cWGS Infants

Published on
Oct 1, 2021
in Cornerstone Blog
In the News
This week’s roundup features new partnerships, novel findings, and exciting approaches to diagnosing rare conditions.

CHOP Researchers Develop Method to Diagnose Aplastic Anemia More Effectively

Published on
Sep 20, 2021
in Press Releases
Study finds two laboratory findings can distinguish the autoimmune pathogenesis of aplastic anemia from other inherited bone marrow disorders.

In The News: Football Concussions, Early Intervention Referrals, Mitochondrial DNA, Panama TV, ‘Research in Motion,’ Bone Marrow Failure

Published on
Oct 23, 2020
in Cornerstone Blog
In the News
This week’s roundup features research reinforcing the need for better universal surveillance for developmental delays and increased access to early intervention. This and more In The News.

Targeting Abnormal Signals Suggests Novel Method to Treat a Rare Childhood Blood Disease

Published on
Oct 9, 2018
in Press Releases
In Animal Study, CHOP Hematologist Restores Blood Cell Function in Fanconi Anemia

CHOP's Foerderer Awards Support Novel Biomedical Research Studies

Published on
Mar 29, 2016
in Cornerstone Blog
Christoph Seiler, PhD, received a Foerderer Fund for Excellence award at The Children’s Hospital of Philadelphia in 2015 to study this mechanism. German-born Dr. Seiler pointed out that “Foerderer,” in German, means supporter or sponsor. Its name is therefore apt, because the internal award program spurs research projects that need a bit of support to generate pilot data that can later help those projects stand out in the competitive awarding of external funds.

International Team Finds Blood Disorder Mutation

Published on
Nov 26, 2014
in Cornerstone Blog
An international team of gene experts has identified a mutation that causes aplastic anemia, a serious blood disorder in which the bone marrow fails to produce normal amounts of blood cells.

Rescuing Mutation May Operate in Bone Marrow Failure

Published on
Nov 19, 2014
in Cornerstone Blog
Bone marrow failure syndromes are rare disorders in which the bone marrow does not produce enough blood cells, increasing the risk for life-threatening bleeding, anemia, and infections.
1 - 10 of 14